132 related articles for article (PubMed ID: 34954457)
1. Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma.
Kim H; Heo CM; Oh J; Chung HH; Lee EM; Park J; Lee SH; Lee KH; Lee KT; Lee JK; Cho YK; Park JK
Transl Oncol; 2022 Feb; 16():101321. PubMed ID: 34954457
[TBL] [Abstract][Full Text] [Related]
2. Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker.
Song BG; Kwon W; Kim H; Lee EM; Han YM; Kim H; Byun Y; Lee KB; Lee KH; Lee KT; Lee JK; Jang JY; Park JK
Front Oncol; 2020; 10():616440. PubMed ID: 33680936
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma.
Varillas JI; Zhang J; Chen K; Barnes II; Liu C; George TJ; Fan ZH
Theranostics; 2019; 9(5):1417-1425. PubMed ID: 30867841
[No Abstract] [Full Text] [Related]
4. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma.
Torphy RJ; Tignanelli CJ; Kamande JW; Moffitt RA; Herrera Loeza SG; Soper SA; Yeh JJ
PLoS One; 2014; 9(2):e89474. PubMed ID: 24586805
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study.
Lee HS; Jung EH; Shin H; Park CS; Park SB; Jung DE; Leem G; Kim SJ; Jo JH; Chung MJ; Park JY; Bang S; Park SW; Song SY
Front Oncol; 2023; 13():1206565. PubMed ID: 37736542
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice.
Zhao X; Ma Y; Dong X; Zhang Z; Tian X; Zhao X; Yang Y
Hepatobiliary Surg Nutr; 2021 Dec; 10(6):796-810. PubMed ID: 35004946
[TBL] [Abstract][Full Text] [Related]
8. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
[TBL] [Abstract][Full Text] [Related]
9. Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival.
Amantini C; Morelli MB; Nabissi M; Piva F; Marinelli O; Maggi F; Bianchi F; Bittoni A; Berardi R; Giampieri R; Santoni G
Front Oncol; 2019; 9():874. PubMed ID: 31552188
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma.
Chang MC; Chang YT; Chen JY; Jeng YM; Yang CY; Tien YW; Yang SH; Chen HL; Liang TY; Wang CF; Lee EY; Chang YC; Lee WH
Clin Chem; 2016 Mar; 62(3):505-13. PubMed ID: 26861552
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status: Results of the Prospective CLUSTER Study.
Gemenetzis G; Groot VP; Yu J; Ding D; Teinor JA; Javed AA; Wood LD; Burkhart RA; Cameron JL; Makary MA; Weiss MJ; He J; Wolfgang CL
Ann Surg; 2018 Sep; 268(3):408-420. PubMed ID: 30080739
[TBL] [Abstract][Full Text] [Related]
12. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
[TBL] [Abstract][Full Text] [Related]
14. Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients.
Nitschke C; Markmann B; Tölle M; Kropidlowski J; Belloum Y; Goetz MR; Schlüter H; Kwiatkowski M; Sinn M; Izbicki J; Pantel K; Güngör C; Uzunoglu FG; Wikman H
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139565
[TBL] [Abstract][Full Text] [Related]
15. Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer.
Wei T; Zhang X; Zhang Q; Yang J; Chen Q; Wang J; Li X; Chen J; Ma T; Li G; Gao S; Lou J; Que R; Wang Y; Dang X; Zheng L; Liang T; Bai X
Cancer Lett; 2019 Jun; 452():237-243. PubMed ID: 30905814
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of circulating tumor microemboli in patients with pancreatic ductal adenocarcinoma.
Wu G; Zhu R; Li Y; Zhao Y; Dai M
Oncol Lett; 2018 May; 15(5):7376-7382. PubMed ID: 29725451
[TBL] [Abstract][Full Text] [Related]
17. Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma.
White MG; Lee A; Vicente D; Hall C; Kim MP; Katz MHG; Lee JE; Ikoma N; Lucci A; Tzeng CD
Ann Surg Oncol; 2021 Aug; 28(8):4615-4622. PubMed ID: 33415562
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
[TBL] [Abstract][Full Text] [Related]
19. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
[TBL] [Abstract][Full Text] [Related]
20. Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis.
Stoecklein NH; Fluegen G; Guglielmi R; Neves RPL; Hackert T; Birgin E; Cieslik SA; Sudarsanam M; Driemel C; van Dalum G; Franken A; Niederacher D; Neubauer H; Fehm T; Rox JM; Böhme P; Häberle L; Göring W; Esposito I; Topp SA; Coumans FAW; Weitz J; Knoefel WT; Fischer JC; Bork U; Rahbari NN
Mol Cancer; 2023 Nov; 22(1):181. PubMed ID: 37957606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
